Cargando…
Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer
BACKGROUND: Geriatric 8 (G8) and instrumental activities of daily living (IADL) are recommended to predict overall survival (OS) or risk of serious adverse events (SAEs) in older cancer patients. However, the clinical utility is relatively unknown in older patients suffering malnutrition with gastro...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264801/ https://www.ncbi.nlm.nih.gov/pubmed/37324017 http://dx.doi.org/10.3389/fonc.2023.1110236 |
_version_ | 1785058404297867264 |
---|---|
author | Doi, Ayako Mizukami, Takuro Takeda, Hiroyuki Umemoto, Kumiko Arai, Hiroyuki Horie, Yoshiki Izawa, Naoki Ogura, Takashi Sunakawa, Yu |
author_facet | Doi, Ayako Mizukami, Takuro Takeda, Hiroyuki Umemoto, Kumiko Arai, Hiroyuki Horie, Yoshiki Izawa, Naoki Ogura, Takashi Sunakawa, Yu |
author_sort | Doi, Ayako |
collection | PubMed |
description | BACKGROUND: Geriatric 8 (G8) and instrumental activities of daily living (IADL) are recommended to predict overall survival (OS) or risk of serious adverse events (SAEs) in older cancer patients. However, the clinical utility is relatively unknown in older patients suffering malnutrition with gastrointestinal (GI) cancer, including gastric cancer (GC) and pancreatic cancer (PC). MATERIALS AND METHODS: We retrospectively included patients aged ≥65 years with GC, PC, and colorectal cancer (CRC) who received a G8 questionnaire at first visit from April 2018 to March 2020. The associations between G8/IADL and safety or OS were assessed in patients with advanced/unresectable tumors. RESULTS: Of 207 patients (median age: 75 years), the median G8 score was 10.5 and normal G8 score rate was 6.8%. Both the median G8 score and normal G8 (>14) score rate numerically increased in the order of GC < PC < CRC. There was no clear association between the G8 standard cutoff value of 14 and SAEs or OS. However, OS was significantly longer in patients with G8 >11 than in those with G8 ≤11 (19.3 vs. 10.5 months, p = 0.0017). Furthermore, OS was significantly better in patients with normal IADL than in those with abnormal IADL (17.6 vs. 11.4 months, p = 0.049). CONCLUSION: The G8 cutoff value of 14 would not be clinically useful in patients with GI cancer for predicting OS or SAEs; however, the cutoff value of 11 and IADL may be useful to predict OS for older patients with GI cancers including GC and PC. |
format | Online Article Text |
id | pubmed-10264801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102648012023-06-15 Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer Doi, Ayako Mizukami, Takuro Takeda, Hiroyuki Umemoto, Kumiko Arai, Hiroyuki Horie, Yoshiki Izawa, Naoki Ogura, Takashi Sunakawa, Yu Front Oncol Oncology BACKGROUND: Geriatric 8 (G8) and instrumental activities of daily living (IADL) are recommended to predict overall survival (OS) or risk of serious adverse events (SAEs) in older cancer patients. However, the clinical utility is relatively unknown in older patients suffering malnutrition with gastrointestinal (GI) cancer, including gastric cancer (GC) and pancreatic cancer (PC). MATERIALS AND METHODS: We retrospectively included patients aged ≥65 years with GC, PC, and colorectal cancer (CRC) who received a G8 questionnaire at first visit from April 2018 to March 2020. The associations between G8/IADL and safety or OS were assessed in patients with advanced/unresectable tumors. RESULTS: Of 207 patients (median age: 75 years), the median G8 score was 10.5 and normal G8 score rate was 6.8%. Both the median G8 score and normal G8 (>14) score rate numerically increased in the order of GC < PC < CRC. There was no clear association between the G8 standard cutoff value of 14 and SAEs or OS. However, OS was significantly longer in patients with G8 >11 than in those with G8 ≤11 (19.3 vs. 10.5 months, p = 0.0017). Furthermore, OS was significantly better in patients with normal IADL than in those with abnormal IADL (17.6 vs. 11.4 months, p = 0.049). CONCLUSION: The G8 cutoff value of 14 would not be clinically useful in patients with GI cancer for predicting OS or SAEs; however, the cutoff value of 11 and IADL may be useful to predict OS for older patients with GI cancers including GC and PC. Frontiers Media S.A. 2023-05-31 /pmc/articles/PMC10264801/ /pubmed/37324017 http://dx.doi.org/10.3389/fonc.2023.1110236 Text en Copyright © 2023 Doi, Mizukami, Takeda, Umemoto, Arai, Horie, Izawa, Ogura and Sunakawa https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Doi, Ayako Mizukami, Takuro Takeda, Hiroyuki Umemoto, Kumiko Arai, Hiroyuki Horie, Yoshiki Izawa, Naoki Ogura, Takashi Sunakawa, Yu Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer |
title | Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer |
title_full | Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer |
title_fullStr | Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer |
title_full_unstemmed | Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer |
title_short | Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer |
title_sort | clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264801/ https://www.ncbi.nlm.nih.gov/pubmed/37324017 http://dx.doi.org/10.3389/fonc.2023.1110236 |
work_keys_str_mv | AT doiayako clinicalutilityofgeriatricassessmenttoolsinolderpatientswithgastrointestinalcancer AT mizukamitakuro clinicalutilityofgeriatricassessmenttoolsinolderpatientswithgastrointestinalcancer AT takedahiroyuki clinicalutilityofgeriatricassessmenttoolsinolderpatientswithgastrointestinalcancer AT umemotokumiko clinicalutilityofgeriatricassessmenttoolsinolderpatientswithgastrointestinalcancer AT araihiroyuki clinicalutilityofgeriatricassessmenttoolsinolderpatientswithgastrointestinalcancer AT horieyoshiki clinicalutilityofgeriatricassessmenttoolsinolderpatientswithgastrointestinalcancer AT izawanaoki clinicalutilityofgeriatricassessmenttoolsinolderpatientswithgastrointestinalcancer AT oguratakashi clinicalutilityofgeriatricassessmenttoolsinolderpatientswithgastrointestinalcancer AT sunakawayu clinicalutilityofgeriatricassessmenttoolsinolderpatientswithgastrointestinalcancer |